u 69593 has been researched along with staurosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, G; Dawson, SA; Goswami, R | 2 |
2 other study(ies) available for u 69593 and staurosporine
| Article | Year |
|---|---|
Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11kappa 7) to apoptosis-inducing drugs by a mechanism that may involve ceramide.
Topics: Analgesics; Androstadienes; Animals; Apoptosis; Benzeneacetamides; Cell Line, Transformed; Cell Survival; Ceramides; Chromones; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Gene Expression; Mice; Morpholines; Narcotics; Neuroblastoma; Neurons; Pyrrolidines; Receptors, Opioid, kappa; Staurosporine; Time Factors; Wortmannin | 1997 |
Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons.
Topics: Androstadienes; Animals; Apoptosis; Benzeneacetamides; Cell Line; Cell Survival; Chick Embryo; Cyclic AMP; Endorphins; Enzyme Inhibitors; Mice; Narcotics; Neurons; Pyrrolidines; Receptors, Opioid, kappa; Staurosporine; Wortmannin | 1998 |